Caribou Biosciences, Inc. (CRBU)
0.4232
-0.02
(-4.90%)
USD |
NASDAQ |
Oct 30, 16:00
0.43
+0.01
(+1.61%)
After-Hours: 20:00
Caribou Biosciences Price : 0.4232 for Oct. 30, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | 0.445 | 0.4453 | 0.4135 | 0.4232 | 2.306M |
| Oct 29, 2026 | 0.4871 | 0.4995 | 0.4448 | 0.445 | 2.838M |
| Oct 28, 2026 | 0.4687 | 0.4915 | 0.4607 | 0.4894 | 1.055M |
| Oct 27, 2026 | 0.4872 | 0.4948 | 0.4553 | 0.4607 | 2.368M |
| Oct 26, 2026 | 0.5328 | 0.5359 | 0.4909 | 0.4922 | 1.934M |
| Oct 23, 2026 | 0.5499 | 0.5768 | 0.5328 | 0.5328 | 2.156M |
| Oct 22, 2026 | 0.528 | 0.5641 | 0.5207 | 0.56 | 2.784M |
| Oct 21, 2026 | 0.5199 | 0.55 | 0.5116 | 0.5444 | 2.264M |
| Oct 20, 2026 | 0.4694 | 0.5254 | 0.4625 | 0.519 | 3.412M |
| Oct 19, 2026 | 0.4644 | 0.478 | 0.4594 | 0.464 | 3.801M |
| Oct 16, 2026 | 0.47 | 0.4781 | 0.4491 | 0.4699 | 2.945M |
| Oct 15, 2026 | 0.46 | 0.4767 | 0.4465 | 0.4647 | 2.881M |
| Oct 14, 2026 | 0.4772 | 0.4842 | 0.4448 | 0.4601 | 3.710M |
| Oct 13, 2026 | 0.482 | 0.495 | 0.45 | 0.47 | 4.546M |
| Oct 12, 2026 | 0.452 | 0.5069 | 0.4449 | 0.4969 | 5.264M |
| Oct 09, 2026 | 0.46 | 0.5194 | 0.4425 | 0.4602 | 9.738M |
| Oct 08, 2026 | 0.5938 | 0.5968 | 0.4503 | 0.4812 | 19.34M |
| Oct 07, 2026 | 0.636 | 0.67 | 0.546 | 0.6174 | 37.51M |
| Oct 06, 2026 | 1.19 | 1.215 | 1.13 | 1.135 | 5.939M |
| Oct 05, 2026 | 1.22 | 1.24 | 1.17 | 1.19 | 1.547M |
| Oct 02, 2026 | 1.24 | 1.24 | 1.215 | 1.22 | 866573.0 |
| Oct 01, 2026 | 1.27 | 1.285 | 1.22 | 1.22 | 687396.0 |
| Sep 30, 2026 | 1.278 | 1.285 | 1.25 | 1.27 | 845067.0 |
| Sep 29, 2026 | 1.25 | 1.265 | 1.22 | 1.24 | 637085.0 |
| Sep 28, 2026 | 1.25 | 1.26 | 1.22 | 1.23 | 818633.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Anavex Life Sciences Corp. | 1.19 |
| Intellia Therapeutics, Inc. | 12.47 |
| Vir Biotechnology, Inc. | 11.30 |
| Vaxcyte, Inc. | 62.03 |
| Foghorn Therapeutics, Inc. | 2.08 |
Price Related Metrics
| PS Ratio | 4.056 |
| Price to Book Value | 0.4573 |
| Earnings Yield | -254.6% |
| Market Cap | 44.86M |